Market Research

APAC Induced Pluripotent Stem Cells (iPSCs) Market - Industry Trends and Forecast to 2029

Best Price Guarantee Length Publisher Published Date SKU
from $3,500 219 Pages Data Bridge Market Research November, 2021 DAABD17215777
Best Price Guarantee
Price from $3,500
Length 219 Pages
Publisher Data Bridge Market Research
Published Date November, 2021
SKU DAABD17215777

APAC Induced Pluripotent Stem Cells (iPSCs) Market - Industry Trends and Forecast to 2029

Asia-Pacific induced pluripotent stem cells (iPSCs) market is projected to register a substantial CAGR of 12.2% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021 and the forecast period is 2022 to 2029.
Market Segmentation:
Asia-Pacific induced pluripotent stem cells (iPSCs), By Cell Source (Skin Cells and Blood Cells), Type (Human IPSCs and Mouse IPSCs), Product (Instruments, Consumables & Kits and Services), Applications (Academic Research, Regenerative Medicine, Cellular Therapy, Toxicology Screening, Drug Discovery and Development, Disease Modelling, Stem Cell Banking, 3D Bio printing and Others), End User (Biotechnology & Pharmaceutical Companies, Research Laboratories, Diagnostic Laboratories and Others), Distribution Channel (Direct Tender and Retail Sales), Country (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines and Rest of Asia-Pacific) – Industry Trends & Forecast to 2029.

Some of the major factors contributing to the growth of the Asia-Pacific induced pluripotent stem cells (iPSCs) market are:
Emerging technological advancements in iPSCs.
Increasing awareness of stem cell therapy.
Growing biotechnology sector with good research investment.

Market Players:

The key market players for Asia-Pacific induced pluripotent stem cells (iPSCs) market are listed below:
Thermo Fisher Scientific Inc.
FUJIFILM Corporation
Hopstem Biotechnology LLC.
Takara Bio Inc.
Lonza.
R & D Systems, Inc.
Charles River Laboratories International, Inc.
Corning Incorporated
REPROCELL Inc.
Merck KGaA and among others.


1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market
1.4 Limitations
1.5 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Dbmr Tripod Data Validation Model
2.6 Multivariate Modelling
2.7 Cell Source Lifeline Curve
2.8 Primary Interviews With Key Opinion Leaders
2.9 Dbmr Market Position Grid
2.10 Market Application Coverage Grid
2.11 Vendor Share Analysis
2.12 Secondary Sources
2.13 Assumptions
3 Executive Summary
4 Premium Insights
5 Asia Pacific Medical Carts Market: Regulations
5.1 Regulation In U.S.
5.2 Regulation In Canada
5.3 Regulation In Europe
5.4 Regulation In India
5.5 Regualtion In Japan
 
6 Market Overview
6.1 Drivers
6.1.1 Wide Range Of Clinical Application Of Induced Pluripotent Stem Cells
6.1.2 Emerging Technological Advantages Of Ipscs
6.1.3 Rising Prevalence Of Several Chronic Diseases
6.1.4 Increasing Adoption Of Stem Cell Therapy
6.1.5 Growing Biotechnology Sector With Better Investment
6.2 Restraint
6.2.1 High Cost Associated With Stem Cell Therapies And Large-scale Applications Of Ipscs
6.2.2 Availability Of Alternatives For Tumor Treatment
6.2.3 Adverse Effects Of Stem Cell Transplants
6.3 Opportunities
6.3.1 Increasing Number Of Pipeline Products
6.3.2 Increasing Interest Of Personalized Medicine
6.3.3 Surge In Healthcare Expenditure
6.3.4 Strategic Initiatives By Key Market Players
6.4 Challenges
6.4.1 Genomic Instability Of Ipscs Is The Key Market Challenge
6.4.2 Lack Of Skilled Professionals
6.4.3 Stringent Regulatory Framework
7 Impact Of Covid-19 On The Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market
7.1 Impact On Price
7.2 Impact On Demand
7.3 Impact On Supply Chain
7.4 Strategic Decisions By Manufacturers
7.5 Conclusion
8 Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market, By Cell Source
8.1 Overview
8.2 Skin Cells
8.2.1 Fibroblast
8.2.2 Keratinocytes
8.2.3 Adipose Derived Stem Cells
8.2.4 Hepatocytes
8.2.5 Melanocytes
8.2.6 Neural Stem Cells
8.2.7 Others
8.3 Blood Cells
8.3.1 Peripheral Blood
8.3.2 Cord Blood Endothelial Cells
8.3.3 Cord Blood Stem Cells
8.3.4 Others
9 Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market, By Type
9.1 Overview
9.2 Human Ipscs
9.3 Mouse Ipscs
10 Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market, By Product
10.1 Overview
10.2 Consumables & Kits
10.2.1 Reprogramming Kits
10.2.2 Media
10.2.3 Transfection Kits
10.2.4 Cell Identification Kits
10.2.5 Accessories
10.2.6 Others
10.3 Services
10.4 Instruments
10.4.1 Imaging Systems
10.4.2 Electroporation Device
10.4.3 Incubators
10.4.4 Others
11 Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market, By Application
11.1 Overview
11.2 Drug Discovery And Development
11.3 Academic Research
11.4 Disease Modelling
11.5 Cellular Therapy
11.6 Regenerative Medicine
11.7 Toxicology Screening
11.8 Stem Cell Banking
11.9 3d Bioprinting
11.10 Others
12 Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market, By End User
12.1 Overview
12.2 Biotechnology & Pharmaceutical Companies
12.3 Research Laboratories
12.4 Diagnostic Laboratories
12.5 Others
13 Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market, By Distribution Channel
13.1 Overview
13.2 Direct Tender
13.3 Retail Sales
14 Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market, By Region
14.1 Asia-pacific
14.1.1 China
14.1.2 Japan
14.1.3 India
14.1.4 South Korea
14.1.5 Australia
14.1.6 Singapore
14.1.7 Thailand
14.1.8 Malaysia
14.1.9 Indonesia
14.1.10 Philippines
14.1.11 Rest Of Asia-pacific
15 Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market: Company Landscape
15.1 Company Share Analysis: Asia Pacific
16 Swot Analysis
 
17 Company Profile
17.1 Fujifilm Corporation
17.1.1 Company Snapshot
17.1.2 Revenue Analysis
17.1.3 Company Share Analysis
17.1.4 Product Portfolio
17.1.5 Recent Development
17.1.5.1 Acquisition
17.2 Thermo Fisher Scientific Inc.
17.2.1 Company Snapshot
17.2.2 Revenue Analysis
17.2.3 Company Share Analysis
17.2.4 Product Portfolio
17.2.5 Recent Developments
17.2.5.1 Event
17.2.5.2 Acquisition
17.3 Lonza.
17.3.1 Company Snapshot
17.3.2 Revenue Analysis
17.3.3 Company Share Analysis
17.3.4 Product Portfolio
17.3.5 Recent Developments
17.3.5.1 Expansion
17.4 Merck Kgaa
17.4.1 Company Snapshot
17.4.2 Revenue Analysis
17.4.3 Company Share Analysis
17.4.4 Product Portfolio
17.4.5 Recent Development
17.4.5.1 Agreement
17.5 Evotec Se.
17.5.1 Company Snapshot
17.5.2 Revenue Analysis
17.5.3 Company Share Analysis
17.5.4 Product Portfolio
17.5.5 Recent Developments
17.5.5.1 Agreement
17.5.5.2 Collaboration
 
17.6 Applied Stemcell.
17.6.1 Company Snapshot
17.6.2 Product Portfolio
17.6.3 Recent Developments
17.6.3.1 Product Launch
17.7 Axol Bioscience Ltd.
17.7.1 Company Snapshot
17.7.2 Product Portfolio
17.7.3 Recent Developments
17.7.3.1 Merger
17.7.3.2 Product Launch
17.8 Cell Applications, Inc.
17.8.1 Company Snapshot
17.8.2 Product Portfolio
17.8.3 Recent Development
17.8.3.1 Partnership
17.9 Charles River Laboratories International, Inc.
17.9.1 Company Snapshot
17.9.2 Revenue Analysis
17.9.3 Product Portfolio
17.9.4 Recent Development
17.9.4.1 Acquisition
17.10 Citius Pharmaceuticals, Inc.
17.10.1 Company Snapshot
17.10.2 Product Portfolio
17.10.3 Recent Development
17.10.3.1 Agreement
17.11 Corning Incorporated
17.11.1 Company Snapshot
17.11.2 Revenue Analysis
17.11.3 Product Portfolio
17.11.4 Recent Development
17.11.4.1 Agreement
17.12 Fate Therapeutics
17.12.1 Company Snapshot
17.12.2 Product Portfolio
17.12.3 Recent Development
17.12.3.1 Clinical Trial
 
17.13 Genecopoeia, Inc.
17.13.1 Company Snapshot
17.13.2 Product Portfolio
17.13.3 Recent Development
17.14 Hopstem Biotechnology Llc.
17.14.1 Company Snapshot
17.14.2 Product Portfolio
17.14.3 Recent Development
17.14.3.1 Partnership
17.15 Horizon Discovery Ltd.
17.15.1 Company Snapshot
17.15.2 Product Portfolio
17.15.3 Recent Development
17.16 Lumacyte
17.16.1 Company Snapshot
17.16.2 Product Portfolio
17.16.3 Recent Development
17.16.3.1 Collaboration
17.17 R & D Systems, Inc.
17.17.1 Company Snapshot
17.17.2 Revenue Analysis
17.17.3 Product Portfolio
17.17.4 Recent Development
17.18 Reprocell Inc.
17.18.1 Company Snapshot
17.18.2 Product Portfolio
17.18.3 Recent Developments
17.18.3.1 Collaboration
17.18.3.2 Facility Expansion
17.18.3.3 Service Launch
17.19 Takara Bio Inc.
17.19.1 Company Snapshot
17.19.2 Revenue Analysis
17.19.3 Product Portfolio
17.19.4 Recent Developments
17.19.4.1 New Facility Launch
 
17.20 Universal Cells Inc. (An Astellas Company)
17.20.1 Company Snapshot
17.20.2 Revenue Analysis
17.20.3 Product Portfolio
17.20.4 Recent Development
17.20.4.1 Acquisition
18 Questionnaire
19 Related Reports
 
List Of Tables
Table 1 New Cancer Cases, Ages 85+, In The U.S.
Table 2 Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market, By Cell Source, 2020-2029 (Usd Million)
Table 3 Asia Pacific Skin Cells In Induced Pluripotent Stem Cells (Ipscs) Market, By Region, 2020-2029 (Usd Million)
Table 4 Asia Pacific Skin Cells In Induced Pluripotent Stem Cells (Ipscs) Market, By Cell Source, 2020-2029 (Usd Million)
Table 5 Asia Pacific Blood Cells In Induced Pluripotent Stem Cells (Ipscs) Market, By Region, 2020-2029 (Usd Million)
Table 6 Asia Pacific Blood Cells In Induced Pluripotent Stem Cells (Ipscs) Market, By Cell Source, 2020-2029 (Usd Million)
Table 7 Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market, By Type, 2020-2029 (Usd Million)
Table 8 Asia Pacific Human Ipscs In Induced Pluripotent Stem Cells (Ipscs) Market, By Region, 2020-2029 (Usd Million)
Table 9 Asia Pacific Mouse Ipscs In Induced Pluripotent Stem Cells (Ipscs) Market, By Region, 2020-2029 (Usd Million)
Table 10 Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market, By Product, 2020-2029 (Usd Million)
Table 11 Asia Pacific Consumables & Kits In Induced Pluripotent Stem Cells (Ipscs) Market, By Region, 2020-2029 (Usd Million)
Table 12 Asia Pacific Consumables & Kits In Induced Pluripotent Stem Cells (Ipscs) Market, By Product, 2020-2029 (Usd Million)
Table 13 Asia Pacific Services In Induced Pluripotent Stem Cells (Ipscs) Market, By Region, 2020-2029 (Usd Million)
Table 14 Asia Pacific Instruments In Induced Pluripotent Stem Cells (Ipscs) Market, By Region, 2020-2029 (Usd Million)
Table 15 Asia Pacific Instruments In Induced Pluripotent Stem Cells (Ipscs) Market, By Product, 2020-2029 (Usd Million)
Table 16 Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market, By Application, 2020-2029 (Usd Million)
Table 17 Asia Pacific Drug Discovery And Development In Induced Pluripotent Stem Cells (Ipscs) Market, By Region, 2020-2029 (Usd Million)
Table 18 Asia Pacific Academic Research In Induced Pluripotent Stem Cells (Ipscs) Market, By Region, 2020-2029 (Usd Million)
Table 19 Asia Pacific Disease Modelling In Induced Pluripotent Stem Cells (Ipscs) Market, By Region, 2020-2029 (Usd Million)
Table 20 Asia Pacific Cellular Therapy In Induced Pluripotent Stem Cells (Ipscs) Market, By Region, 2020-2029 (Usd Million)
Table 21 Asia Pacific Regenerative Medicine In Induced Pluripotent Stem Cells (Ipscs) Market, By Region, 2020-2029 (Usd Million)
Table 22 Asia Pacific Toxicology Screening In Induced Pluripotent Stem Cells (Ipscs) Market, By Region, 2020-2029 (Usd Million)
Table 23 Asia Pacific Stem Cell Banking In Induced Pluripotent Stem Cells (Ipscs) Market, By Region, 2020-2029 (Usd Million)
Table 24 Asia Pacific 3d Bioprinting In Induced Pluripotent Stem Cells (Ipscs) Market, By Region, 2020-2029 (Usd Million)
Table 25 Asia Pacific Others In Induced Pluripotent Stem Cells (Ipscs) Market, By Region, 2020-2029 (Usd Million)
Table 26 Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market, By End User, 2020-2029 (Usd Million)
Table 27 Asia Pacific Biotechnology & Pharmaceutical Companies In Induced Pluripotent Stem Cells (Ipscs) Market, By Region, 2020-2029 (Usd Million)
Table 28 Asia Pacific Research Laboratories In Induced Pluripotent Stem Cells (Ipscs) Market, By Region, 2020-2029 (Usd Million)
Table 29 Asia Pacific Diagnostic Laboratories In Induced Pluripotent Stem Cells (Ipscs) Market, By Region, 2020-2029 (Usd Million)
Table 30 Asia Pacific Others In Induced Pluripotent Stem Cells (Ipscs) Market, By Region, 2020-2029 (Usd Million)
Table 31 Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market, By Distribution Channel, 2020-2029 (Usd Million)
Table 32 Asia Pacific Direct Tender In Induced Pluripotent Stem Cells (Ipscs) Market, By Region, 2020-2029 (Usd Million)
Table 33 Asia Pacific Retail Sales In Induced Pluripotent Stem Cells (Ipscs) Market, By Region, 2020-2029 (Usd Million)
Table 34 Asia-pacific Induced Pluripotent Stem Cells (Ipscs) Market, By Country, 2020-2029 (Usd Million)
Table 35 Asia-pacific Induced Pluripotent Stem Cells (Ipscs) Market, By Cell Source, 2020-2029 (Usd Million)
Table 36 Asia-pacific Skin Cells In Induced Pluripotent Stem Cells (Ipscs) Market, By Cell Source, 2020-2029 (Usd Million)
Table 37 Asia-pacific Blood Cells In Induced Pluripotent Stem Cells (Ipscs) Market, By Cell Source, 2020-2029 (Usd Million)
Table 38 Asia-pacific Induced Pluripotent Stem Cells (Ipscs) Market, By Type, 2020-2029 (Usd Million)
Table 39 Asia-pacific Induced Pluripotent Stem Cells (Ipscs) Market, By Product, 2020-2029 (Usd Million)
Table 40 Asia-pacific Instruments In Induced Pluripotent Stem Cells (Ipscs) Market, By Product, 2020-2029 (Usd Million)
Table 41 Asia-pacific Consumables & Kits In Induced Pluripotent Stem Cells (Ipscs) Market, By Product, 2020-2029 (Usd Million)
Table 42 Asia-pacific Induced Pluripotent Stem Cells (Ipscs) Market, By Application, 2020-2029 (Usd Million)
Table 43 Asia-pacific Induced Pluripotent Stem Cells (Ipscs) Market, By End User, 2020-2029 (Usd Million)
Table 44 Asia-pacific Induced Pluripotent Stem Cells (Ipscs) Market, By Distribution Channel, 2020-2029 (Usd Million)
Table 45 China Induced Pluripotent Stem Cells (Ipscs) Market, By Cell Source, 2020-2029 (Usd Million)
Table 46 China Skin Cells In Induced Pluripotent Stem Cells (Ipscs) Market, By Cell Source, 2020-2029 (Usd Million)
Table 47 China Blood Cells In Induced Pluripotent Stem Cells (Ipscs) Market, By Cell Source, 2020-2029 (Usd Million)
Table 48 China Induced Pluripotent Stem Cells (Ipscs) Market, By Type, 2020-2029 (Usd Million)
Table 49 China Induced Pluripotent Stem Cells (Ipscs) Market, By Product, 2020-2029 (Usd Million)
Table 50 China Instruments In Induced Pluripotent Stem Cells (Ipscs) Market, By Product, 2020-2029 (Usd Million)
Table 51 China Consumables & Kits In Induced Pluripotent Stem Cells (Ipscs) Market, By Product, 2020-2029 (Usd Million)
Table 52 China Induced Pluripotent Stem Cells (Ipscs) Market, By Application, 2020-2029 (Usd Million)
Table 53 China Induced Pluripotent Stem Cells (Ipscs) Market, By End User, 2020-2029 (Usd Million)
Table 54 China Induced Pluripotent Stem Cells (Ipscs) Market, By Distribution Channel, 2020-2029 (Usd Million)
Table 55 Japan Induced Pluripotent Stem Cells (Ipscs) Market, By Cell Source, 2020-2029 (Usd Million)
Table 56 Japan Skin Cells In Induced Pluripotent Stem Cells (Ipscs) Market, By Cell Source, 2020-2029 (Usd Million)
Table 57 Japan Blood Cells In Induced Pluripotent Stem Cells (Ipscs) Market, By Cell Source, 2020-2029 (Usd Million)
Table 58 Japan Induced Pluripotent Stem Cells (Ipscs) Market, By Type, 2020-2029 (Usd Million)
Table 59 Japan Induced Pluripotent Stem Cells (Ipscs) Market, By Product, 2020-2029 (Usd Million)
Table 60 Japan Instruments In Induced Pluripotent Stem Cells (Ipscs) Market, By Product, 2020-2029 (Usd Million)
Table 61 Japan Consumables & Kits In Induced Pluripotent Stem Cells (Ipscs) Market, By Product, 2020-2029 (Usd Million)
Table 62 Japan Induced Pluripotent Stem Cells (Ipscs) Market, By Application, 2020-2029 (Usd Million)
Table 63 Japan Induced Pluripotent Stem Cells (Ipscs) Market, By End User, 2020-2029 (Usd Million)
Table 64 Japan Induced Pluripotent Stem Cells (Ipscs) Market, By Distribution Channel, 2020-2029 (Usd Million)
Table 65 India Induced Pluripotent Stem Cells (Ipscs) Market, By Cell Source, 2020-2029 (Usd Million)
Table 66 India Skin Cells In Induced Pluripotent Stem Cells (Ipscs) Market, By Cell Source, 2020-2029 (Usd Million)
Table 67 India Blood Cells In Induced Pluripotent Stem Cells (Ipscs) Market, By Cell Source, 2020-2029 (Usd Million)
Table 68 India Induced Pluripotent Stem Cells (Ipscs) Market, By Type, 2020-2029 (Usd Million)
Table 69 India Induced Pluripotent Stem Cells (Ipscs) Market, By Product, 2020-2029 (Usd Million)
Table 70 India Instruments In Induced Pluripotent Stem Cells (Ipscs) Market, By Product, 2020-2029 (Usd Million)
Table 71 India Consumables & Kits In Induced Pluripotent Stem Cells (Ipscs) Market, By Product, 2020-2029 (Usd Million)
Table 72 India Induced Pluripotent Stem Cells (Ipscs) Market, By Application, 2020-2029 (Usd Million)
Table 73 India Induced Pluripotent Stem Cells (Ipscs) Market, By End User, 2020-2029 (Usd Million)
Table 74 India Induced Pluripotent Stem Cells (Ipscs) Market, By Distribution Channel, 2020-2029 (Usd Million)
Table 75 South Korea Induced Pluripotent Stem Cells (Ipscs) Market, By Cell Source, 2020-2029 (Usd Million)
Table 76 South Korea Skin Cells In Induced Pluripotent Stem Cells (Ipscs) Market, By Cell Source, 2020-2029 (Usd Million)
Table 77 South Korea Blood Cells In Induced Pluripotent Stem Cells (Ipscs) Market, By Cell Source, 2020-2029 (Usd Million)
Table 78 South Korea Induced Pluripotent Stem Cells (Ipscs) Market, By Type, 2020-2029 (Usd Million)
Table 79 South Korea Induced Pluripotent Stem Cells (Ipscs) Market, By Product, 2020-2029 (Usd Million)
Table 80 South Korea Instruments In Induced Pluripotent Stem Cells (Ipscs) Market, By Product, 2020-2029 (Usd Million)
Table 81 South Korea Consumables & Kits In Induced Pluripotent Stem Cells (Ipscs) Market, By Product, 2020-2029 (Usd Million)
Table 82 South Korea Induced Pluripotent Stem Cells (Ipscs) Market, By Application, 2020-2029 (Usd Million)
Table 83 South Korea Induced Pluripotent Stem Cells (Ipscs) Market, By End User, 2020-2029 (Usd Million)
Table 84 South Korea Induced Pluripotent Stem Cells (Ipscs) Market, By Distribution Channel, 2020-2029 (Usd Million)
Table 85 Australia Induced Pluripotent Stem Cells (Ipscs) Market, By Cell Source, 2020-2029 (Usd Million)
Table 86 Australia Skin Cells In Induced Pluripotent Stem Cells (Ipscs) Market, By Cell Source, 2020-2029 (Usd Million)
Table 87 Australia Blood Cells In Induced Pluripotent Stem Cells (Ipscs) Market, By Cell Source, 2020-2029 (Usd Million)
Table 88 Australia Induced Pluripotent Stem Cells (Ipscs) Market, By Type, 2020-2029 (Usd Million)
Table 89 Australia Induced Pluripotent Stem Cells (Ipscs) Market, By Product, 2020-2029 (Usd Million)
Table 90 Australia Instruments In Induced Pluripotent Stem Cells (Ipscs) Market, By Product, 2020-2029 (Usd Million)
Table 91 Australia Consumables & Kits In Induced Pluripotent Stem Cells (Ipscs) Market, By Product, 2020-2029 (Usd Million)
Table 92 Australia Induced Pluripotent Stem Cells (Ipscs) Market, By Application, 2020-2029 (Usd Million)
Table 93 Australia Induced Pluripotent Stem Cells (Ipscs) Market, By End User, 2020-2029 (Usd Million)
Table 94 Australia Induced Pluripotent Stem Cells (Ipscs) Market, By Distribution Channel, 2020-2029 (Usd Million)
Table 95 Singapore Induced Pluripotent Stem Cells (Ipscs) Market, By Cell Source, 2020-2029 (Usd Million)
Table 96 Singapore Skin Cells In Induced Pluripotent Stem Cells (Ipscs) Market, By Cell Source, 2020-2029 (Usd Million)
Table 97 Singapore Blood Cells In Induced Pluripotent Stem Cells (Ipscs) Market, By Cell Source, 2020-2029 (Usd Million)
Table 98 Singapore Induced Pluripotent Stem Cells (Ipscs) Market, By Type, 2020-2029 (Usd Million)
Table 99 Singapore Induced Pluripotent Stem Cells (Ipscs) Market, By Product, 2020-2029 (Usd Million)
Table 100 Singapore Instruments In Induced Pluripotent Stem Cells (Ipscs) Market, By Product, 2020-2029 (Usd Million)
Table 101 Singapore Consumables & Kits In Induced Pluripotent Stem Cells (Ipscs) Market, By Product, 2020-2029 (Usd Million)
Table 102 Singapore Induced Pluripotent Stem Cells (Ipscs) Market, By Application, 2020-2029 (Usd Million)
Table 103 Singapore Induced Pluripotent Stem Cells (Ipscs) Market, By End User, 2020-2029 (Usd Million)
Table 104 Singapore Induced Pluripotent Stem Cells (Ipscs) Market, By Distribution Channel, 2020-2029 (Usd Million)
Table 105 Thailand Induced Pluripotent Stem Cells (Ipscs) Market, By Cell Source, 2020-2029 (Usd Million)
Table 106 Thailand Skin Cells In Induced Pluripotent Stem Cells (Ipscs) Market, By Cell Source, 2020-2029 (Usd Million)
Table 107 Thailand Blood Cells In Induced Pluripotent Stem Cells (Ipscs) Market, By Cell Source, 2020-2029 (Usd Million)
Table 108 Thailand Induced Pluripotent Stem Cells (Ipscs) Market, By Type, 2020-2029 (Usd Million)
Table 109 Thailand Induced Pluripotent Stem Cells (Ipscs) Market, By Product, 2020-2029 (Usd Million)
Table 110 Thailand Instruments In Induced Pluripotent Stem Cells (Ipscs) Market, By Product, 2020-2029 (Usd Million)
Table 111 Thailand Consumables & Kits In Induced Pluripotent Stem Cells (Ipscs) Market, By Product, 2020-2029 (Usd Million)
Table 112 Thailand Induced Pluripotent Stem Cells (Ipscs) Market, By Application, 2020-2029 (Usd Million)
Table 113 Thailand Induced Pluripotent Stem Cells (Ipscs) Market, By End User, 2020-2029 (Usd Million)
Table 114 Thailand Induced Pluripotent Stem Cells (Ipscs) Market, By Distribution Channel, 2020-2029 (Usd Million)
Table 115 Malaysia Induced Pluripotent Stem Cells (Ipscs) Market, By Cell Source, 2020-2029 (Usd Million)
Table 116 Malaysia Skin Cells In Induced Pluripotent Stem Cells (Ipscs) Market, By Cell Source, 2020-2029 (Usd Million)
Table 117 Malaysia Blood Cells In Induced Pluripotent Stem Cells (Ipscs) Market, By Cell Source, 2020-2029 (Usd Million)
Table 118 Malaysia Induced Pluripotent Stem Cells (Ipscs) Market, By Type, 2020-2029 (Usd Million)
Table 119 Malaysia Induced Pluripotent Stem Cells (Ipscs) Market, By Product, 2020-2029 (Usd Million)
Table 120 Malaysia Instruments In Induced Pluripotent Stem Cells (Ipscs) Market, By Product, 2020-2029 (Usd Million)
Table 121 Malaysia Consumables & Kits In Induced Pluripotent Stem Cells (Ipscs) Market, By Product, 2020-2029 (Usd Million)
Table 122 Malaysia Induced Pluripotent Stem Cells (Ipscs) Market, By Application, 2020-2029 (Usd Million)
Table 123 Malaysia Induced Pluripotent Stem Cells (Ipscs) Market, By End User, 2020-2029 (Usd Million)
Table 124 Malaysia Induced Pluripotent Stem Cells (Ipscs) Market, By Distribution Channel, 2020-2029 (Usd Million)
Table 125 Indonesia Induced Pluripotent Stem Cells (Ipscs) Market, By Cell Source, 2020-2029 (Usd Million)
Table 126 Indonesia Skin Cells In Induced Pluripotent Stem Cells (Ipscs) Market, By Cell Source, 2020-2029 (Usd Million)
Table 127 Indonesia Blood Cells In Induced Pluripotent Stem Cells (Ipscs) Market, By Cell Source, 2020-2029 (Usd Million)
Table 128 Indonesia Induced Pluripotent Stem Cells (Ipscs) Market, By Type, 2020-2029 (Usd Million)
Table 129 Indonesia Induced Pluripotent Stem Cells (Ipscs) Market, By Product, 2020-2029 (Usd Million)
Table 130 Indonesia Instruments In Induced Pluripotent Stem Cells (Ipscs) Market, By Product, 2020-2029 (Usd Million)
Table 131 Indonesia Consumables & Kits In Induced Pluripotent Stem Cells (Ipscs) Market, By Product, 2020-2029 (Usd Million)
Table 132 Indonesia Induced Pluripotent Stem Cells (Ipscs) Market, By Application, 2020-2029 (Usd Million)
Table 133 Indonesia Induced Pluripotent Stem Cells (Ipscs) Market, By End User, 2020-2029 (Usd Million)
Table 134 Indonesia Induced Pluripotent Stem Cells (Ipscs) Market, By Distribution Channel, 2020-2029 (Usd Million)
Table 135 Philippines Induced Pluripotent Stem Cells (Ipscs) Market, By Cell Source, 2020-2029 (Usd Million)
Table 136 Philippines Skin Cells In Induced Pluripotent Stem Cells (Ipscs) Market, By Cell Source, 2020-2029 (Usd Million)
Table 137 Philippines Blood Cells In Induced Pluripotent Stem Cells (Ipscs) Market, By Cell Source, 2020-2029 (Usd Million)
Table 138 Philippines Induced Pluripotent Stem Cells (Ipscs) Market, By Type, 2020-2029 (Usd Million)
Table 139 Philippines Induced Pluripotent Stem Cells (Ipscs) Market, By Product, 2020-2029 (Usd Million)
Table 140 Philippines Instruments In Induced Pluripotent Stem Cells (Ipscs) Market, By Product, 2020-2029 (Usd Million)
Table 141 Philippines Consumables & Kits In Induced Pluripotent Stem Cells (Ipscs) Market, By Product, 2020-2029 (Usd Million)
Table 142 Philippines Induced Pluripotent Stem Cells (Ipscs) Market, By Application, 2020-2029 (Usd Million)
Table 143 Philippines Induced Pluripotent Stem Cells (Ipscs) Market, By End User, 2020-2029 (Usd Million)
Table 144 Philippines Induced Pluripotent Stem Cells (Ipscs) Market, By Distribution Channel, 2020-2029 (Usd Million)
Table 145 Rest Of Asia-pacific Induced Pluripotent Stem Cells (Ipscs) Market, By Cell Source, 2020-2029 (Usd Million)
List Of Figures
Figure 1 Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market: Segmentation
Figure 2 Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market: Data Triangulation
Figure 3 Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market: Droc Analysis
Figure 4 Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market: Asia Pacific Vs Regional Market Analysis
Figure 5 Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market: Company Research Analysis
Figure 6 Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market: Interview Demographics
Figure 7 Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market: Dbmr Market Position Grid
Figure 8 Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market: Market Application Coverage Grid
Figure 9 Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market: Vendor Share Analysis
Figure 10 Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market: Segmentation
Figure 11 The Wide Range Of Clinical Application Of Induced Pluripotent Stem Cells (Ipsc) Are Expected To Drive The Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market In The Forecast Period Of 2022 To 2029
Figure 12 Skin Cells Segment Is Expected To Account For The Largest Share Of The Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market In 2022 & 2029
Figure 13 North America Is Expected To Dominate The Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market, And Asia-pacific Is Expected To Grow With The Highest Cagr In The Forecast Period Of 2022 To 2029
Figure 14 Drivers, Restraints, Opportunities, And Challenges Of Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market
Figure 15 Prevalence Of Chronic Diseases
Figure 16 Number Of People With Diabetes (Million) Among Ages 20–79 Years
Figure 17 Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market: By Cell Source, 2021
Figure 18 Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market: By Cell Source, 2020-2029 (Usd Million)
Figure 19 Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market: By Cell Source, Cagr (2022-2029)
Figure 20 Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market: By Cell Source, Lifeline Curve
Figure 21 Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market: By Type, 2021
Figure 22 Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market: By Type, 2020-2029 (Usd Million)
Figure 23 Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market: By Type, Cagr (2022-2029)
Figure 24 Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market: By Type, Lifeline Curve
Figure 25 Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market: By Product, 2021
Figure 26 Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market: By Product, 2020-2029 (Usd Million)
Figure 27 Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market: By Product, Cagr (2022-2029)
Figure 28 Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market: By Product, Lifeline Curve
Figure 29 Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market: By Application, 2021
Figure 30 Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market: By Application, 2020-2029 (Usd Million)
Figure 31 Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market: By Application, Cagr (2022-2029)
Figure 32 Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market: By Application, Lifeline Curve
Figure 33 Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market: By End User, 2021
Figure 34 Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market: By End User, 2020-2029 (Usd Million)
Figure 35 Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market: By End User, Cagr (2022-2029)
Figure 36 Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market: By End User, Lifeline Curve
Figure 37 Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market: By Distribution Channel, 2021
Figure 38 Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market: By Distribution Channel, 2020-2029 (Usd Million)
Figure 39 Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market: By Distribution Channel, Cagr (2022-2029)
Figure 40 Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market: By Distribution Channel, Lifeline Curve
Figure 41 Asia-pacific Induced Pluripotent Stem Cells (Ipscs) Market: Snapshot (2021)
Figure 42 Asia-pacific Induced Pluripotent Stem Cells (Ipscs) Market: By Country (2021)
Figure 43 Asia-pacific Induced Pluripotent Stem Cells (Ipscs) Market: By Country (2022 & 2029)
Figure 44 Asia-pacific Induced Pluripotent Stem Cells (Ipscs) Market: By Country (2021 & 2029)
Figure 45 Asia-pacific Induced Pluripotent Stem Cells (Ipscs) Market: By Cell Source (2022-2029)
Figure 46 Asia Pacific Induced Pluripotent Stem Cells (Ipscs) Market: Company Share 2021 (%)

$3,500
$4,200

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings